TERT gene mutations have been identified in a substantial proportion of GBM cases, with a frequency reaching up to 80% (Aquilanti et al., 2021; Giunco et al., 2023; Mosrati et al., 2015; Simon et al., 2015). This evidence concerns the gene TERT and glioblastoma.